The CGGGG insertion/deletion polymorphism of theIRF5promoter is a strong risk factor for primary Sjögren's syndrome-Reference-Cited by-同舟云学术

The CGGGG insertion/deletion polymorphism of theIRF5promoter is a strong risk factor for primary Sjögren's syndrome

Published:2009-07 Issue:7 Volume:60 Page:1991-1997
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Miceli-Richard Corinne,Gestermann Nicolas,Ittah Marc,Comets Emmanuelle,Loiseau Pascale,Puechal Xavier,Hachulla Eric,Gottenberg Jacques-Eric,Lebon Pierre,Becquemont Laurent,Mariette Xavier

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.24662/fullpdf

Reference14 articles.

1. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects;Hjelmervik;Arthritis Rheum,2005

2. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome;Gottenberg;Proc Natl Acad Sci U S A,2006

3. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus;Baechler;Proc Natl Acad Sci U S A,2003

4. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus;Graham;Proc Natl Acad Sci U S A,2007

5. Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis;Rueda;Arthritis Rheum,2006

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review of Sjögren's syndrome: Classification criteria, risk factors, and signaling pathways;Heliyon;2024-09

2. New investigational drugs to treat Sjogren's syndrome: lessons learnt from immunology;Expert Opinion on Investigational Drugs;2024-01-31

3. Genetic alterations leading to autoimmunity;The Rose and Mackay Textbook of Autoimmune Diseases;2024

4. Risk factors for primary Sjögren’s Syndrome: a systematic review and meta-analysis;Clinical Rheumatology;2022-12-19

5. Interferon signature in systemic autoimmune diseases: what does it mean?;RMD Open;2022-12